Home > Insider Trading > Filing (0001415889-24-022447)

Filing Details

Accession Number:: 0001415889-24-022447
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-08-28 16:30:14
Reporting Period:: 2024-08-26

Accepted Time:: 2024-08-28 16:30:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1082554	United Therapeutics Corp	UTHR	Pharmaceutical Preparations (2834)	521984749

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1106578	A Martine Rothblatt	C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910	Chairperson & Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-08-26	269	$129.49	399	No	4	M	Direct
Common Stock	Disposition	2024-08-26	28	$347.27	371	No	4	S	Direct
Common Stock	Disposition	2024-08-26	196	$348.20	175	No	4	S	Direct
Common Stock	Disposition	2024-08-26	22	$349.21	153	No	4	S	Direct
Common Stock	Disposition	2024-08-26	23	$350.86	130	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2024-08-26	269	$0.00	269	$129.49

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2014-12-31	2024-12-31	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	166	Indirect	By Spouse
Common Stock	245,909	Indirect	By Trust
Common Stock	28,170	Indirect	By Trust
Common Stock	324,518	Indirect	By Trust
Common Stock	45,596	Indirect	By Trust

Footnotes

This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023.
This transaction was executed in multiple trades at prices ranging from $349.78 to $347.715. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $347.86 to $348.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
Reflects the correction of a clerical error in the reporting person's Form 4 filed on August 21, 2024, which error caused the reporting person's stock option holding to be overreported by 3600 shares in such Form 4 and in the reporting person's subsequently filed Form 4.